 |
인쇄하기
취소
|
KFDA approves 23 bioequivalence tests in 4Q
The Korea Food and Drug Administration (KFDA) said it approved 23 bioequivalence tests in the fourth quarter of this year.
The drug authority said that based on the results of bioequivalence tests, it will examine the efficacy or risks associated with the drugs in the human body.
Four drug firms, including Dongkook Pharm and Shinpoong Pharm, applied for the bioequivalence test for Novarti...
The drug authority said that based on the results of bioequivalence tests, it will examine the efficacy or risks associated with the drugs in the human body.
Four drug firms, including Dongkook Pharm and Shinpoong Pharm, applied for the bioequivalence test for Novarti...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.